Below is a weekly earnings calendar of the most important upcoming quarterly reports schedule to be released by publicly traded companies. There are also earnings previews for select companies. Please check back often. This earnings calendar is updated weekly.
Earnings Calendar Highlights
MONDAY
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Noteworthy Earnings Reports: Cal-Maine Foods (CALM)” data-reactid=”19″>Noteworthy Earnings Reports: Cal-Maine Foods (CALM)
<h3 class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SEE ALSO: The 20 Best Stocks to Buy for 2020” data-reactid=”20″>SEE ALSO: The 20 Best Stocks to Buy for 2020
TUESDAY
Noteworthy Earnings Reports: N/A
WEDNESDAY
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Earnings Spotlight: Constellation Brands (STZ, $189.53) – Spirits giant Constellation Brands isn’t enjoying quite the bump it thought it would following its August 2018 bet on Canopy Growth (CGC) – a $4 billion investment raising its stake in the Canadian cannabis company from 9.9% to 38%. Since then, STZ shares have lost about 9% versus a 14% gain for the broader market. That included a wide underperformance of 11 percentage points in 2019. Its last earnings report, in October, saw the company top earnings expectations handily and raise its full-year profit guidance, but Constellation also reported an 8.9% decline in wine sales, as well as a $54 million loss related to Canopy’s operations. Indeed, STZ said it recognized an $839 million decrease in its CGC investment. Argus analyst John Staszak wasn’t deterred, raising his price target from $220 per share to $230 and maintaining his Buy rating on the stock. He cites recent brand additions and better-than-expected margins as reasons for optimism. Up next: The company’s results for the fiscal third quarter ended Nov. 30, due out ahead of the Jan. 8 opening bell. Analysts are looking for a 1% decline in revenues to $1.95 billion, and a more considerable 21.9% drop in profits to $1.85 per share.” data-reactid=”24″>Earnings Spotlight: Constellation Brands (STZ, $189.53) – Spirits giant Constellation Brands isn’t enjoying quite the bump it thought it would following its August 2018 bet on Canopy Growth (CGC) – a $4 billion investment raising its stake in the Canadian cannabis company from 9.9% to 38%. Since then, STZ shares have lost about 9% versus a 14% gain for the broader market. That included a wide underperformance of 11 percentage points in 2019. Its last earnings report, in October, saw the company top earnings expectations handily and raise its full-year profit guidance, but Constellation also reported an 8.9% decline in wine sales, as well as a $54 million loss related to Canopy’s operations. Indeed, STZ said it recognized an $839 million decrease in its CGC investment. Argus analyst John Staszak wasn’t deterred, raising his price target from $220 per share to $230 and maintaining his Buy rating on the stock. He cites recent brand additions and better-than-expected margins as reasons for optimism. Up next: The company’s results for the fiscal third quarter ended Nov. 30, due out ahead of the Jan. 8 opening bell. Analysts are looking for a 1% decline in revenues to $1.95 billion, and a more considerable 21.9% drop in profits to $1.85 per share.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Earnings Spotlight: Bed Bath & Beyond (BBBY, $16.08) – Home-good retailer Bed Bath & Beyond, whose shares are mired in a roughly five-year downtrend, but BBBY has more than doubled since bouncing off the bottom in mid-August. Among the drivers: reports that the company was looking into selling off assets, including its Cost Plus World Market division; the hiring of former Target (TGT) executive Mark Tritton as president and CEO; and a pre-Christmas culling of several senior leaders, including the chief merchandising, marketing and brand officers. A few analysts have stepped into the bull camp, including Wedbush’s Seth Basham (Outperform, equivalent of Buy), who writes, "We would not be surprised to hear Mr. Tritton point to hundreds of millions of dollars of cost savings opportunities in SG&A and (cost of goods sold) (likely partially offset by some necessary investments), but as importantly we will focus on his ideas for reinvigorating traffic in stores." That said, Bed Bath still has more improving to do. For its fiscal third quarter ended November, Wall Street’s pros are projecting a 9.9% decline in revenues to $2.85 billion, and an 88.9% plunge in profits to 2 cents per share. That report should come after Wednesday’s close.” data-reactid=”25″>Earnings Spotlight: Bed Bath & Beyond (BBBY, $16.08) – Home-good retailer Bed Bath & Beyond, whose shares are mired in a roughly five-year downtrend, but BBBY has more than doubled since bouncing off the bottom in mid-August. Among the drivers: reports that the company was looking into selling off assets, including its Cost Plus World Market division; the hiring of former Target (TGT) executive Mark Tritton as president and CEO; and a pre-Christmas culling of several senior leaders, including the chief merchandising, marketing and brand officers. A few analysts have stepped into the bull camp, including Wedbush’s Seth Basham (Outperform, equivalent of Buy), who writes, “We would not be surprised to hear Mr. Tritton point to hundreds of millions of dollars of cost savings opportunities in SG&A and (cost of goods sold) (likely partially offset by some necessary investments), but as importantly we will focus on his ideas for reinvigorating traffic in stores.” That said, Bed Bath still has more improving to do. For its fiscal third quarter ended November, Wall Street’s pros are projecting a 9.9% decline in revenues to $2.85 billion, and an 88.9% plunge in profits to 2 cents per share. That report should come after Wednesday’s close.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Other Noteworthy Reports: Lennar (LEN), MSC Industrial (MSM), Walgreens Boots Alliance (WBA)” data-reactid=”26″>Other Noteworthy Reports: Lennar (LEN), MSC Industrial (MSM), Walgreens Boots Alliance (WBA)
<h3 class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SEE ALSO: The 20 Best ETFs to Buy for a Prosperous 2020” data-reactid=”27″>SEE ALSO: The 20 Best ETFs to Buy for a Prosperous 2020
THURSDAY
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Earnings Spotlight: KB Home (KBH, $34.91) – Homebuilders slowed down some during the final quarter of 2019, but KB Home still is sitting on a roughly 76% gain over the past 12 months. It’s not alone. Numerous homebuilders have been thriving amid gradual but steady improvement in the U.S. housing market, prompting a few analysts to continue bumping up their expectations. RBC Capital analyst Mike Dahl (Outperform) raised his price target from $36 per share to $38 and still calls the stock his "top idea" in the homebuilding industry. Argus’ Chris Graja kept his Hold rating on the stock in December, but did bring up his full-year EPS estimate by about 10% thanks to the macro environment. KB Home’s upcoming report, for the fiscal fourth quarter ended November, is due out after the Jan. 9 close. Analysts are looking for a 19.2% jump in revenues to $1.61 billion, and a 33.3% pop in profits to $1.28 per share.” data-reactid=”29″>Earnings Spotlight: KB Home (KBH, $34.91) – Homebuilders slowed down some during the final quarter of 2019, but KB Home still is sitting on a roughly 76% gain over the past 12 months. It’s not alone. Numerous homebuilders have been thriving amid gradual but steady improvement in the U.S. housing market, prompting a few analysts to continue bumping up their expectations. RBC Capital analyst Mike Dahl (Outperform) raised his price target from $36 per share to $38 and still calls the stock his “top idea” in the homebuilding industry. Argus’ Chris Graja kept his Hold rating on the stock in December, but did bring up his full-year EPS estimate by about 10% thanks to the macro environment. KB Home’s upcoming report, for the fiscal fourth quarter ended November, is due out after the Jan. 9 close. Analysts are looking for a 19.2% jump in revenues to $1.61 billion, and a 33.3% pop in profits to $1.28 per share.
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Noteworthy Earnings Reports: Acuity Brands (AYI), WD-40 (WDFC)” data-reactid=”30″>Noteworthy Earnings Reports: Acuity Brands (AYI), WD-40 (WDFC)
FRIDAY
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="Noteworthy Earnings Reports: Infosys (INFY)” data-reactid=”32″>Noteworthy Earnings Reports: Infosys (INFY)
Reporting schedules provided by Briefing.com and company websites. Earnings estimate data provided by Thomson Reuters via Yahoo! Finance, and FactSet via MarketWatch.
<h3 class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="SEE ALSO: Hedge Funds’ Top 25 Blue-Chip Stocks to Buy Now” data-reactid=”34″>SEE ALSO: Hedge Funds’ Top 25 Blue-Chip Stocks to Buy Now
<p class="canvas-atom canvas-text Mb(1.0em) Mb(0)–sm Mt(0.8em)–sm" type="text" content="EDITOR’S PICKS
” data-reactid=”35″>EDITOR’S PICKS
Copyright 2018-2020 The Kiplinger Washington Editors
Add Comment